(BN) VIX Didn’t Update for 30 Minutes as Options Quotes Got Erratic


VIX Didn’t Update for 30 Minutes as Options Quotes Got Erratic
2015-08-24 15:03:17.843 GMT


By Callie Bost
(Bloomberg) -- For a brief period this morning, anxiety got
too high to measure in the U.S. options market.
The Chicago Board Options Exchange Volatility Index failed
to update for about 30 minutes after the open of stock trading
at 9:30 a.m., data sent to Bloomberg show. Trading in the
options from which the VIX is derived was too disjointed to
calculate a value, its overseer said.
“Because of market conditions, the quoting in S&P 500 and
S&P 500 options was erratic,” said Suzanne Cosgrove, a
spokeswoman for the CBOE. “As more people resume quoting, it’ll
level out.”
In times of stress, traders use the VIX to gauge levels of
market turbulence. The gauge reflects the cost of options that
are used, among other things, to protect against losses in
shares, so its level is viewed to gauge how cautious investors
are toward equities.
Today, they are very cautious. The Standard & Poor’s 500
Index plunged more than 5 percent in the first minutes of
trading as a global rout in risk assets circled the globe for a
third day. The VIX’s highest recorded level of the day was 53.29
-- at one minute before 10 a.m.
As of 11:00, selling had diminished, the S&P 500 had cut
its worst losses in half, and the VIX was at 36.47.

For Related News and Information:
After Months in Denial VIX Hears Signals Sent by Other Markets
Momentum Trade Gives Evidence of Its Own Mortality: A Down Week
Tension Runs High in VIX as Stock Insurance Costs Most Since ’06
VIX Most-Traded Options: VIX INDEX OMST <GO>
Options Market Analysis: NI OMA <GO>
Top Stories on Stocks: TOP STK <GO>
Feature Stories on Stocks: TNI STK GREET <GO>

To contact the reporter on this story:
Callie Bost in New York at +1-212-617-3495 or
cbost2@bloomberg.net
To contact the editors responsible for this story:
Jeff Sutherland at +1-212-617-6567 or
jsutherlan13@bloomberg.net
Chris Nagi

>>> GOGO - almost flat : FAA clears Gogo's next generation in-flight internet te

GOGO : FAA clears Gogo's next generation in-flight internet technology 

Received the final Supplemental Type Certificate (STC) from the FAA required to launch Gogo's 2Ku next generation satellite connectivity service. The technology is currently installed on Gogo's 737-500 test plane and is now cleared for in-flight testing. Gogo expects to launch commercial service of its 2Ku technology later this year.

Seven commercial airlines have signed up for either a trial or fleet deployment of 2Ku covering more than 500 commercial aircraft. Gogo expects to launch commercial service later this year and begin rapid installation of the backlog of 500 aircraft in 2016.

2Ku is expected to deliver peak speeds of more than 70 Mbps to the aircraft, which is more than 20 times the bandwidth provided by Gogo's first generation Air to Ground solution in the U.S. More information about this technology can be found here. - Source TradeTheNews.com

(BI) Gilead $140 Billion Spending Power Could Allow Bristol-Myers Buy


Gilead $140 Billion Spending Power Could Allow Bristol-Myers Buy
2015-08-24 14:36:57.649 GMT

BI BIOT GLOB SBKEYS
The largest M&A target for Gilead suggested in a recent BI survey
was Bristol-Myers Squibb, which is within reach. Gilead may be
able to push for a 4x debt-to-Ebitda ratio to borrow another $72
billion. Assuming cash funding of 50%, this gives Gilead $140
billion in spending power, making Bristol-Myers's $100 billion
enterprise value an easy reach, even with a 30% premium.
Bristol-Myers's 33x forward P/E may mean such a premium is
unnecessary. The question is whether Gilead has an appetite for
such a deal.

|0|0|567848|234538944|MMDL 235295986|MMDL 235295986|

This research note has been published by Bloomberg Intelligence.
For more information, see BI <GO>
-0- Aug/24/2015 14:36 GMT

>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance
: MOBI -12%, TOUR -5.6%

M&A news: SO -1.6% (acquiring GAS)

Select fan favorites showing weakness: FIT -14.5%, SHAK -13.6%, CYBR -13.5%, GPRO -11.9%, SWKS -11.9%, FEYE -11.5%, NFLX -10.1%, MBLY -9.1%, SBUX -7.5%, PANW -7.5%, SUNE -7.3%, TSLA -7.1%, TWTR -7.1%, AAPL -6.5%
Select China related names showing weakness after Shanhai was down 8.5% overnight: NQ -21%, BTU -18.5%, QIHU -16%, SFUN -14.1%, WBAI -12.9%, CSIQ -11.8%, JD -10.2%, BITA -9.6%, BABA -9.1%, CHL -8.5%, SPWR -8.3%, MGM -8.2%, WUBA -8.1%, SINA -8.1%
Select metals/mining stocks trading lower: CLF -11.2%, FCX -7.8%, X -7%, BHP -5.9%, MT -5.7%
Select oil/gas related names showing early weakness: PACD -12.3%, PBR -9.5%, LINE -5.4%, HAL -5.3%

Other news: VTL -80.8% (nnounces that topline results of its VTI-208 trial fail to achieve primary or secondary endpoints of improvement in overall survival; ), NBG -13.5% (cont uncertainty in Greece after snap elections called), DGLY -10.5% (Bloomberg reports that Sony (SNE) is considering entering drone market), RAD -9.7% (still checking), ESLT -7% (still checking, but was awarded $27 million contract to supply command and control and artillery systems to an Asia-Pacific Country), HLT -6.1% (still checking), GALE -5.2% (announce?s that the Independent Data Monitoring Committee has recommended to GALE that it can reduce the cardiac toxicity monitoring for patients in its NeuVax Phase 3 PRESENT clinical trial), CIE -3.3% (to sell its 40% participating interest in Blocks 21/09 and 20/11 offshore Angola for $1.75 bln to Empresa Pública), ALKS -1.7% (announces that FDA has advised it will not be able to complete its review of the New Drug Application for ARISTADA for the treatment of schizophrenia)

Analyst comments: WLL -10.7% (downgraded to Neutral at BofA/Merrill ), SPLK -8.3% (downgraded to Hold at Summit Research), GM -6.8% (resumed with a Underweight at Morgan Stanley), MRO -6.7% (downgraded to Neutral at BofA/Merrill ), KGC -1.9% (downgraded to Underperform at RBC Capital Mkts)

>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance
: N/A.

M&A news: GAS +7.3% (Southern Company (SO) to Acquire AGL Resources (GAS) in $12 Billion Transaction -- AGL Resources' shareholders will be entitled to receive $66 in cash)

Other news: SPEX +22.5% (provided an update on its case involving the company's NNPT subsidiary against Huawei), OPXA +15.7% (cont strength from last week), PPHM +7% (Peregrine Pharma and AstraZeneca (AZN) form collaboration to focus on on immuno-oncology combination clinical trial), ACTS +3.1% (Action Semi to purchase for cash up to 48,000,000 of its issued and outstanding ordinary shares through a Dutch Auction Tender Offer), JOE +2.1% (tenders offer to purchase up to 16,666,666 shares of its outstanding common stock at a price of $18.00 per share), EPZM +1.1% (FDA has accepted the company's investigational new drug (IND) application for tazemetostat for the treatment of adults and pediatric patients), .

Analyst comments: N/
A

Reuters - Heineken eyes controlling stake in India's United Breweries

Aug 24 Heineken NV, the world's third-largest brewer, is seeking to raise its stake in India's United Breweries Ltd to gain full management control as it bets on the country's growing thirst for beer, sources with direct knowledge of the matter said.

The Dutch brewer, the single largest shareholder in United Breweries with a 42.07 percent stake, plans to take that holding beyond 50 percent by buying shares from liquor baron Vijay Mallya and his group firms, the sources said.

The stake hike, a bet on one of the world's fastest growing beer markets, will be completed in a phased manner over the next couple of years, said the two sources, who declined to be named as the talks are private.

A spokeswoman for Heineken in Amsterdam declined to comment. A spokesman for UB Group, Mallya's group holding company, said that there had been no discussions on a stake sale in United Breweries.

>>> US Early premarket gappers

Gapping up: OPXA +15.7%, CIE +3.6%, PPHM +2.6%, GALE +1.5%, JOE +0.7%

Gapping down: WBAI -12.9%, NBG -12.8%, PACD -12.3%, CYBR -11.5%, FIT -10.6%, HLT -10.2%, LINE -10%, SFUN -9.6%, IBN -8.7%, TTM -8.6%, BITA -8.5%, MBLY -8.3%, WUBA -8.1%, CSIQ -8.1%, SPWR -7.8%, GPRO -7.6%, TSLA -7.6%, SUNE -7.3%, CHL -7.3%, ESLT -7%, BABA -6.9%, JD -6.8%, SWKS -6.4%, NFLX -6.4%, GM -5.7%, TWTR -5.6%, FEYE -5.5%, HAL -5.2%, SUBX -5.2%, MGM -5.1%, FCX -5%, BHP -4.7%, PANW -4.4%, X -4.4%, MT -4%